(Q47641918)

4 February 2018

title

Incidence and risk factors for tuberculosis in HIV-infected patients while on antiretroviral treatment in Cambodia (English)

1 reference

4 February 2018

0 references

1 reference

5

1 reference

4 February 2018

Johan van Griensven

6

object named as

Johan van Griensven

1 reference

4 February 2018

author name string

Kimcheng Choun

1

1 reference

4 February 2018

Sopheak Thai

2

1 reference

4 February 2018

Reaksmey Pe

3

1 reference

4 February 2018

Natalie Lorent

4

1 reference

4 February 2018

publication date

16 January 2013

1 reference

4 February 2018

Transactions of the Royal Society of Tropical Medicine and Hygiene

published in

1 reference

4 February 2018

volume

107

1 reference

4 February 2018

issue

4

1 reference

4 February 2018

page(s)

235-242

1 reference

4 February 2018

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

cites work

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resources

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

Tuberculosis after HAART initiation in HIV-positive patients from five countries with a high tuberculosis burden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

An algorithm for tuberculosis screening and diagnosis in people with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

Five-year experience with scaling-up access to antiretroviral treatment in an HIV care programme in Cambodia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

Predictors of immune recovery and the association with late mortality while on antiretroviral treatment in Cambodia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

Evaluation of the 2007 WHO guideline to improve the diagnosis of tuberculosis in ambulatory HIV-positive adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

Incidence of treatment-limiting toxicity with stavudine-based antiretroviral therapy in Cambodia: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

Antiretroviral treatment cohort analysis using time-updated CD4 counts: assessment of bias with different analytic methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

Association of body mass index with all-cause and cause-specific mortality: findings from a prospective cohort study in Mumbai (Bombay), India

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

Lower risk of tuberculosis in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

A consistent log-linear relationship between tuberculosis incidence and body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

Body mass index and risk of tuberculosis and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

Incidence of tuberculosis in HIV-infected patients before and after starting combined antiretroviral therapy in 8 sub-Saharan African HIV programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

Current hemoglobin levels are more predictive of disease progression than hemoglobin measured at baseline in patients receiving antiretroviral treatment for HIV type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

Tuberculosis in HIV programmes in lower-income countries: practices and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

An algorithm to optimize viral load testing in HIV-positive patients with suspected first-line antiretroviral therapy failure in Cambodia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

No rebound in tuberculosis in the United States in 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

Risk factors for active tuberculosis among adults on highly active antiretroviral therapy in Africa: a reply

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTRSTMH%2FTRT001

21 January 2018

Identifiers

DOI

10.1093/TRSTMH/TRT001

1 reference

4 February 2018

1 reference

4 February 2018